Alex Rubinsteyn is a computational biology researcher, working as Assistant Professor at University of North Carolina . He is currently working on machine learning applications in cancer immunotherapy and designing computational pipelines for personalized cancer vaccines.
Alex received his PhD in Computer Science from NYU, where he worked on machine learning and runtime compilation for parallel hardware. After grad school he switched over to computational cancer immunotherapy research at the Icahn School of Medicine at Mount Sinai, where he helped start and run three personalized cancer vaccine trials. His current line of research focuses on optimizing personalized vaccination through better genomics and machine learning methods, as well as collaborating heavily with experimentalists to optimize vaccine formulation.